Today's Most Popular
PRoFESS Trial: Stroke Recurrence Comparable with Aspirin Plus Extended-Release Dipyridamole or Clopidogrel Alone - Worldwide Survey Shows People Underestimate Health Behaviors' Link to Cancer
Trend: Number of tools to remotely collect health data growing 
Universal Healthcare Without Politics 
Diabetics, Keep Exercising 
Wirral PCT faces local data privacy backlash 
Viigo Software for your Smartphone 
Nissan Buy Outs, Employment News - EmploymentCrossing.Com - Three Bears Resort, Employment News - EmploymentCrossing.Com
- Tax Credits, Employment News - EmploymentCrossing.Com
PRoFESS Trial: Stroke Recurrence Comparable with Aspirin Plus Extended-Release Dipyridamole or Clopidogrel Alone
Article posted from Americal College of Emergency Physicians (http://www.acep.org/NewsFeed.aspx?id=imn082720081709285259)
Americal College of Emergency Physicians (http://www.acep.org/NewsFeed.aspx?id=imn082720081709285259)
Rates of recurrent stroke were nearly identical with either of two antiplatelet regimens - aspirin plus extended release dipyridamole or clopidogrel alone - in a trial in more than 20,000 patients randomly assigned to one of the two antiplatelet regimens after a recent ischemic stroke.
More Stories in Americal College of Emergency Physicians
- Portable CT Speeds Evaluation for TPA Eligibility
- Lancet: Child Abuse, Neglect Contribute to Ongoing Burden
- CT Colonography Simultaneously Screens for Bone Loss, Colorectal Cancer
- Rapid Response Team Did Not Significantly Improve Outcomes in Study
- Surgery Is Best Option for Some Patients with Refractory Epilepsy
Other Feedables
Belle Feeds - For the feminine palette.
Notable Twitter Users - Will Twitter For Food
Mens Health Feeds - Healthy Feeding
Barack Obama - hungry for change?
Olympic Feeds - Feeding the international sports appetite.- more feedables...
Feedables.com